NeoGenomics, Inc. (NEO) vs DENTSPLY SIRONA Inc. (XRAY)
A side-by-side comparison of NeoGenomics, Inc. and DENTSPLY SIRONA Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.
NEO
NeoGenomics, Inc.
$18.47HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
XRAY
DENTSPLY SIRONA Inc.
$8.67HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
Total return — NEO vs XRAY
growth of $100 · dividends reinvested · last 10yNEO +117.9% (+8.1%/yr)XRAY -83.0% (-16.2%/yr)NEO compounded faster over this window
Log scale — wide-divergence pair
NEO XRAY
NEO vs XRAY: by the numbers
- •XRAY is the larger company ($1.74B vs $475M market cap).
- •Both run net losses; NEO's is the smaller (-6.77% vs -14.99% net margin).
- •NEO grew revenue faster over the past five years (9.41% vs 1.96% CAGR).
- •XRAY pays a dividend (3.66% yield), while NEO is a former payer with no current dividend run rate.
Metrics side by side
Valuation
| Metric | NEO | XRAY |
|---|---|---|
| Forward P/E | 101.08 | 5.68 |
| P/S ratio | 0.62 | 0.48 |
| P/B ratio | 0.60 | 1.29 |
| EV / EBITDA | N/A | 4.46 |
| FCF yield | N/A | 8.23% |
Profitability
| Metric | NEO | XRAY |
|---|---|---|
| Gross margin | 42.92% | 49.52% |
| Operating margin | -8.63% | 11.69% |
| Net margin | -6.77% | -14.99% |
| ROE | -6.60% | -40.41% |
| ROIC | -5.29% | 10.03% |
Dividends
| Metric | NEO | XRAY |
|---|---|---|
| Dividend yield | N/A | 3.66% |
Growth (annualized)
| Metric | NEO | XRAY |
|---|---|---|
| Revenue CAGR (5Y) | 9.41% | 1.96% |
| FCF CAGR (5Y) | N/A | -25.74% |
| Total return CAGR (5Y) | -18.18% | -30.33% |
Frequently asked
- Which has grown faster, NEO or XRAY?
- Over the past five years, NEO grew revenue faster — NEO at a 9.41% CAGR versus XRAY at 1.96%.
- Does NEO or XRAY pay a bigger dividend?
- XRAY pays a dividend (3.66% yield), while NEO is a former payer with no current dividend run rate.
- How have NEO and XRAY total returns compared?
- Over the past 10 years, NEO delivered 8.10% and XRAY delivered -16.27% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
DENTSPLY SIRONA dividend yieldNeoGenomics ROEDENTSPLY SIRONA ROENeoGenomics operating marginDENTSPLY SIRONA operating marginNeoGenomics revenue growthDENTSPLY SIRONA revenue growthNeoGenomics free cash flowDENTSPLY SIRONA free cash flow
NeoGenomics & DENTSPLY SIRONA appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.